IDM Pharma, Inc. (IDMI)

[bowonwing]

as of June 3, 2008, Bonnie Mills, Ph.D. resigned as Vice President, Clinical Operations of IDM Pharma, Inc.

Form 8-K for IDM PHARMA, INC.
15-Jul-2008
Change in Directors or Principal Officers
Item 5.02. Departure of Directors or Principal Officers; Election of Directors;
Appointment of Principal Officers.
Effective as of June 3, 2008, Bonnie Mills, Ph.D. resigned as Vice President, Clinical Operations of IDM Pharma, Inc. (the "Company"). Jeffrey W. Sherman, M.D., Senior Vice President, Research and Development and Chief Medical Officer of the Company, continues to have day to day responsibility for all clinical operations activities of the Company.
On July 9, 2008, Dr. Mills and the Company entered into a letter agreement regarding the terms of her separation from the Company (the "Letter Agreement") and continuation as an ongoing consultant to the Company. Under the terms of the Letter Agreement, Dr. Mills shall be available to provide consulting services to the Company through September 30, 2008 , as determined and requested by Dr. Sherman, and is entitled to the following payments from the Company:
(i) severance payments consisting of nine months of her base salary in effect at the time of her resignation, less required deductions, paid in three installments over the period of six-months from the date of the Letter Agreement and (ii) COBRA health insurance premiums payable until the earlier of June 3, 2009 or the date upon which Dr. Mills becomes employed by another organization offering group health insurance coverage.